Cancer death rates have fallen 27 percent

Jan 9, 2019
Oncology experts say advances in cancer drugs have played a major role.
Cathy Bradley says many cancer patients stay at work because they need the health insurance their employer provides.
Justin Sullivan/Getty Images

Deals aimed at reining in costs of cancer drugs show promise

Jun 6, 2016
Some manufacturers are willing to tie drug price to performance.
Dr. Julie Brahmer (R) and Katie Thornton review PET (Positron Emission Tomography) scans of a patient being treated at the Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, Maryland. 
Win McNamee/Getty Images

Cigna deal calls for rebates if drugs don't perform

May 11, 2016
It's the seventh such deal for the insurance giant, which is putting pressure on drug makers in an effort to keep costs down.
Rosemary Petty, a Publix Supermarket pharmacy technician, counts out a prescription August 7, 2007 in Miami, Florida. 
Joe Raedle/Getty Images

FTC fights against new strategy for delaying generics

Apr 1, 2016
FTC files case against drug maker for deals cut with two generic firms that extend its monopoly
John Moore/Getty Images

Why rare-disease treatments can be big business

Jan 11, 2016
Combined, Shire and Baxalta expect 65 percent of total revenue to come from rare disease treatments.

Police turn to pricey rehab drug for offenders

Nov 4, 2015
The drug, administered once a month, helps ensure patient compliance.

Valeant: how aggressively can a drug company sell

Oct 30, 2015
Valeant is under scrutiny for its business practices.

You’ve got questions. We help you answer them.

Support nonprofit, independent journalism that makes you smarter.

Drug company's subsidies to patients under review

Oct 15, 2015
Assistance programs are also marketing tools that can raise overall costs.